Personal information

Websites & social links

LinkedIn

Other IDs

SciProfiles: 1660336

Countries

Germany

Activities

Collapse all

Employment (2)

Medizinische Hochschule Hannover: Hannover, Niedersachsen, DE

2023-11-12 to present | Postdoctoral Scientist (Department of Human Genetics)
Employment
Source: Self-asserted source
Jonathan Lukas Lühmann

Medizinische Hochschule Hannover: Hannover, Niedersachsen, DE

2020-10-01 to 2023-11-10 | PhD Candidate (Department of Human Genetics)
Employment
Source: Self-asserted source
Jonathan Lukas Lühmann

Education and qualifications (3)

Medizinische Hochschule Hannover: Hannover, Niedersachsen, DE

2020-10-01 to 2023-11-10 | PhD Molecular Medicine
Education
Source: Self-asserted source
Jonathan Lukas Lühmann

Medizinische Hochschule Hannover: Hannover, Niedersachsen, DE

2018-10-01 to 2020-09-23 | M.Sc. Biomedizin
Education
Source: Self-asserted source
Jonathan Lukas Lühmann

Universität Hamburg: Hamburg, Hamburg, DE

2015-10-01 to 2018-08 | B.Sc. Molecular Life Sciences
Education
Source: Self-asserted source
Jonathan Lukas Lühmann

Professional activities (2)

Deutsche Gesellschaft für Humangenetik eV: Berlin, Berlin, DE

2023-01 to present
Membership
Source: Self-asserted source
Jonathan Lukas Lühmann

European Hematology Association: The Hague, NL

2021-03-05 to present | Junior Member
Membership
Source: Self-asserted source
Jonathan Lukas Lühmann

Works (6)

Parallel deletion and duplication at 7q11.23 in a silent carrier for two reciprocal syndromic disorders

American Journal of Medical Genetics Part A
2023-07 | Journal article
DOI: 10.1002/ajmg.a.63215
Contributors: Jonathan Lukas Lühmann; Gunnar Schmidt; Bernd Auber; Anke Katharina Bergmann; Oliver Brandau; Anja Louis; Sabine Hentze; Katrin Eisfeld; Brigitte Schlegelberger; Ruediger Klaes et al.
Source: check_circle
Crossref

CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC)

Cancers
2023-06-13 | Journal article
DOI: 10.3390/cancers15123169
Contributors: Juliette Nowak; Marco Bentele; Ivana Kutle; Katharina Zimmermann; Jonathan Lukas Lühmann; Doris Steinemann; Stephan Kloess; Ulrike Koehl; Willi Roßberg; Amed Ahmed et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Generation of two TMEM16A knockout iPSC clones each from a healthy human iPSC line, from a Cystic Fibrosis patient specific line with p.Phe508del mutation and from the gene corrected iPSC line

Stem Cell Research
2022-10 | Journal article
DOI: 10.1016/j.scr.2022.102918
Part of ISSN: 1873-5061
Contributors: Mark-Christian Jaboreck; Jonathan Lukas Lühmann; Mia Mielenz; Frauke Stanke; Gudrun Göhring; Ulrich Martin; Ruth Olmer; Sylvia Merkert
Source: Self-asserted source
Jonathan Lukas Lühmann

Optical Genome Mapping as a Diagnostic Tool in Pediatric Acute Myeloid Leukemia

Cancers
2022-04-19 | Journal article
DOI: 10.3390/cancers14092058
Contributors: Julia Suttorp; Jonathan Lukas Lühmann; Yvonne Lisa Behrens; Gudrun Göhring; Doris Steinemann; Dirk Reinhardt; Nils von Neuhoff; Markus Schneider
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines

Scientific Reports
2021-11-12 | Journal article
DOI: 10.1038/s41598-021-01689-2
Contributors: Reto Eggenschwiler; Thomas Gschwendtberger; Christian Felski; Christopher Jahn; Florian Langer; Jared Sterneckert; Andreas Hermann; Jonathan Lühmann; Doris Steinemann; Alexandra Haase et al.
Source: check_circle
Crossref

The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia

Cancers
2021-08-30 | Journal article
DOI: 10.3390/cancers13174388
Contributors: Jonathan Lukas Lühmann; Marie Stelter; Marie Wolter; Josephine Kater; Jana Lentes; Anke Katharina Bergmann; Maximilian Schieck; Gudrun Göhring; Anja Möricke; Gunnar Cario et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎
How many people are using ORCID?